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CC BY-NC-ND license.This axiom, applied to health, is as true today as it
was when it was originally quoted in reference to ﬁre
safety. Acute atherothrombotic cardiovascular events such
as acute coronary syndromes, ischemic stroke, and sudden
death are often (nearly 50% of the time) the ﬁrst clinical
manifestation of occult vascular disease in subjects
unaware of existence of pre-symptomatic atherosclerosis.
The overall burden of cardiovascular disease worldwide is
signiﬁcant, and nearly two-thirds of it originates from low-
and middle-income countries (LMIC) [1,2]. This very high
burden of cardiovascular disease in developing nations
threatens the economy of underprivileged nations because
many victims tend to be young with substantial earning
potential. Preventing such ﬁrst and unheralded acute
cardiovascular events is important because adoption of
a healthy lifestyle and risk factor control can prevent such
events in the asymptomatic population as well as in
patients with known cardiovascular disease (primary and
secondary prevention) [3,4]. In this regard, identifying
seemingly healthy and asymptomatic individuals at
potential risk for acute atherothrombotic events in the near
term becomes relevant. At-risk individuals can be cost-
effectively targeted for lifestyle modiﬁcation as well as
more aggressive long-term interventions including phar-
macotherapy (statins, aspirin, etc.), whereas low-risk or
not-at-risk individuals can be spared the expense and side
effects of aggressive pharmacotherapy, and they can
continue to be encouraged to adopt and maintain a healthy
lifestyle [5].
The traditional approach to risk assessment is based on
various risk scores (Framingham risk score, Reynold risk
score, etc.) that tally risk factors associated with cardio-
vascular events, as deﬁned in various epidemiologic
studies. All these indirect methods suffer from the draw-
back that individual risk assessment is difﬁcult; on one
hand, many individuals with such risk factors never
develop cardiovascular events, and on the other, a signiﬁ-
cant number develop cardiovascular events without the
traditional risk factors [5,6]. Identiﬁcation of subclinical
atherosclerosis, the underlying basis for atherothrombosis,
is an appealing target in this regard because it reﬂects the
cumulative end result of known and unknown risk factors
as well as known and unknown risk mitigators. Therefore,
subclinical atherosclerosis is likely to more accurately
identify high-risk as well as very-low-risk individuals [5,6].AL HEART, VOL. 8, NO. 2, 2013
2013: 91-93Furthermore, in developing nations such as India where
a large population of subjects lives in rural areas with
limited access to medical and healthcare information,
knowledge of risk factors is limited and obtaining an
inventory of risk factors may be logistically more chal-
lenging than rapid and early detection of subclinical
atherosclerosis would be. Atherosclerosis tends to involve
multiple arterial beds in the body with the coronary bed
and cerebrovascular bed contributing most to the
life-threatening cardiovascular events. Because imaging of
1 bed may predict disease and events related to another
vascular bed, carotid imaging with ultrasound and/or
coronary imaging, mostly using computed tomography
(CT) calcium scores, are the 2 most commonly employed
modalities for the detection of subclinical atherosclerosis.
In this issue of Global Heart, Singh et al. [7] provide
preliminary data from a cross-sectional study that supports
the potential feasibility of such an approach in a rural
community in Northern India [7]. This study is part of
a much larger multinational effort involving mass screening
and mass community education for prevention of cardio-
vascular disease and promotion of cardiovascular health
(HAPPY [Heart Attack Prevention Program for You] Study)
[8]. The study was conducted in less than a week in
January 2012, taking advantage of the fact that nearly 10
million followers of a local spiritual leader congregate in
the northern Indian town of Sirsa annually during this
time. The investigators used B-mode ultrasound imaging of
both carotid arteries to detect carotid plaque (deﬁned as
protrusion of 1.5 mm or more) and measured intima-
media thickness (IMT) in 771 asymptomatic volunteer
subjects (626 men and 145 women) with each test taking
an average of 3 min. Rapid imaging was made possible by
a semiautomatic system [7]. A simple questionnaire
collected some basic demographic information, and no
blood tests were required. The imaging was performed by
physicians (radiology and cardiology trainees) who had
received 4 h of on-site training prior to implementation of
the screening program. One or more carotid plaques were
detected in nearly 9% of the cohort (10% of men and 4%
of women) who were relatively young (mean age of
40 years), but the prevalence clearly increased with
increasing age [7]. The average IMT was 0.55  0.13 mm,
which also increased with increasing age. The investigators
rightly focused on carotid plaque rather than simply an
IMT, because several studies have shown improved prog-
nostic ability of plaque versus IMT [9,10]. It is of interest to
note that this rural Northern Indian community practices91
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current smoking, and moderate physical activity). The
overall prevalence of carotid plaque (about 9%) was lower
than what was recently reported in another cross-sectional
study (78%), but the patients included in that study were
on an average 28 years older (mean age of 68 years) and the
methodology involved a manual sweep and 3-dimensional
(3D) ultrasound technology to measure plaque and plaque
burden [11]. The 3D ultrasound technique is likely to be
more reliable in identifying carotid plaque [11].
The potential advantages of carotid ultrasound to detect
subclinical atherosclerosis include: its risk-free nature;
relative technical simplicity in completing the assessment
with relatively modest training requirements for perfor-
mance and interpretation of the test; rapid data acquisition;
and known association of carotid plaque with coronary
atherosclerosis and cardiovascular outcomes, especially
when plaque area, plaque volume, or plaque burden are
considered [11e14]. Furthermore, serial carotid ultrasound
examinations are feasible, and changes in carotid plaque
burden may be quantiﬁable, allowing assessment of changes
in plaque burden with time and/or therapy [15].
Although the report by Singh et al. [7] demonstrates
the feasibility of rapid screening for carotid plaque, several
important questions remain to be answered:
1. Does subclinical atherosclerosis detection by carotid
ultrasound ultimately lead to better adoption of and
compliance with risk-mitigating interventions and,
above all, improved clinical outcome compared with
standard risk factorebased assessment and treatment?
2. Does absence of carotid plaque identify a low-risk
population that is unlikely to beneﬁt from aggressive
risk-mitigating pharmacotherapy? This is particularly
important because nearly 30% of subjects without
a carotid plaque may have subclinical coronary
atherosclerosis as detected by coronary calcium scan-
ning by CT [16]. The improved sensitivity of carotid
plaque detection using plaque area/volume measure-
ment with use of 3D ultrasound may further improve
sensitivity and speciﬁcity of carotid ultrasound to
predict coronary atherosclerosis.
3. Could serial carotid ultrasound examinations at inter-
vals identify a larger proportion of subjects with
subclinical atherosclerosis who are likely to beneﬁt from
aggressive interventions?
4. Can the methodology adopted by Singh et al. [7] in
their study be applied in other populations and in other
countries?
5. Will this approach be cost-effective compared with
population-based widespread low-cost preventive
interventions such as a polypill [17] or possibly in the
future, a vaccine against atherosclerosis [18]?
Some but not all observational studies have suggested
that screening for subclinical atherosclerosis (mostly using
coronary CT) may improve the use of risk-mitigatinginterventions among at-risk subjects, but randomized
trials are clearly needed to prove the impact on outcomes
[19e21].
Notwithstanding these limitations of the study by
Singh et al. [7], the investigators deserve to be congratu-
lated on demonstrating the feasibility of a noninvasive risk-
free approach to rapid detection of subclinical carotid
atherosclerosis in a rural setting, paving the way for feasi-
bility of initiating intervention based on the identiﬁcation
of subclinical atherosclerosis and beginning to address the
many unanswered but important questions outlined here.REFERENCES
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